BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21658422)

  • 21. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Lindner E; Nordang GB; Melum E; Flatø B; Selvaag AM; Thorsby E; Kvien TK; Førre OT; Lie BA
    BMC Med Genet; 2007 Jun; 8():33. PubMed ID: 17565662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population.
    Wesoly J; Hu X; Thabet MM; Chang M; Uh H; Allaart CF; Toes RE; Houwing-Duistermaat JJ; Begovich AB; Huizinga TW
    Rheumatology (Oxford); 2007 Apr; 46(4):617-21. PubMed ID: 17135225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.
    Thabet MM; Huizinga TW; Marques RB; Stoeken-Rijsbergen G; Bakker AM; Kurreeman FA; White SJ; Toes RE; van der Helm-van Mil AH
    Ann Rheum Dis; 2009 Nov; 68(11):1775-80. PubMed ID: 19019892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population.
    Carreira PE; Gonzalez-Crespo MR; Ciruelo E; Pablos JL; Santiago B; Gomez-Camara A; Gomez-Reino JJ
    Arthritis Rheum; 2005 Oct; 52(10):3015-9. PubMed ID: 16200608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
    Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population.
    Sánchez E; Alizadeh BZ; Valdigem G; Ortego-Centeno N; Jiménez-Alonso J; de Ramón E; García A; López-Nevot MA; Wijmenga C; Martín J; Koeleman BP
    Hum Immunol; 2007 Jul; 68(7):610-5. PubMed ID: 17584584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
    Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
    Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of protein tyrosine phosphatase non-receptor 22 (PTPN22) rs2476601 and Kruppel-like factor 12 (KLF12) rs1324913 single nucleotide polymorphisms with rheumatoid arthritis in a Latvian population.
    Mihailova A; Mikazane H; Klovins J; Nikitina-Zake L
    Scand J Rheumatol; 2011 Nov; 40(6):491-2. PubMed ID: 22150086
    [No Abstract]   [Full Text] [Related]  

  • 30. Corticotropin-releasing hormone promoter polymorphisms in patients with rheumatoid arthritis from northwest Spain.
    Gonzalez-Gay MA; Hajeer AH; Garcia-Porrua C; Dababneh A; Amoli MM; Botana MA; Thomson W; Llorca J; Ollier WE
    J Rheumatol; 2003 May; 30(5):913-7. PubMed ID: 12734882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.
    Park KS; Park JH; Song YW
    Tissue Antigens; 2008 Oct; 72(4):342-6. PubMed ID: 18700876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.
    Harrison P; Pointon JJ; Farrar C; Brown MA; Wordsworth BP
    Rheumatology (Oxford); 2006 Aug; 45(8):1009-11. PubMed ID: 16490755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis.
    Barton A; Jury F; Eyre S; Bowes J; Hinks A; Ward D; Worthington J
    Arthritis Rheum; 2004 Mar; 50(3):748-52. PubMed ID: 15022315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population.
    Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Pascual-Salcedo D; Balsa A; Pablos JL; García A; González-Escribano MF; Martín J
    J Rheumatol; 2006 Jul; 33(7):1235-9. PubMed ID: 16821265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis.
    Hollis-Moffatt JE; Merriman ME; Rodger RA; Rowley KA; Chapman PT; Dalbeth N; Gow PJ; Harrison AA; Highton J; Jones PB; O'Donnell JL; Stamp LK; Merriman TR
    Ann Rheum Dis; 2009 Aug; 68(8):1340-4. PubMed ID: 18647855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases.
    Martínez A; Varadé J; Márquez A; Cénit MC; Espino L; Perdigones N; Santiago JL; Fernández-Arquero M; de la Calle H; Arroyo R; Mendoza JL; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Arthritis Rheum; 2008 Sep; 58(9):2598-602. PubMed ID: 18759272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population.
    Martinez A; Valdivia A; Pascual-Salcedo D; Lamas JR; Fernández-Arquero M; Balsa A; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
    Rheumatology (Oxford); 2005 Oct; 44(10):1263-6. PubMed ID: 15998632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases.
    Eike MC; Nordang GB; Karlsen TH; Boberg KM; Vatn MH; ; Dahl-Jørgensen K; Rønningen KS; Joner G; Flatø B; Bergquist A; Thorsby E; Førre O; Kvien TK; Undlien DE; Lie BA
    Ann Rheum Dis; 2008 Sep; 67(9):1287-91. PubMed ID: 18065500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10 gene promoter polymorphism in Polish rheumatoid arthritis patients.
    Paradowska-Gorycka A; Trefler J; Maciejewska-Stelmach J; Łacki JK
    Int J Immunogenet; 2010 Aug; 37(4):225-31. PubMed ID: 20477882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.